206 related articles for article (PubMed ID: 15195895)
1. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
[TBL] [Abstract][Full Text] [Related]
3. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
[TBL] [Abstract][Full Text] [Related]
4. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
Sahlin S
Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
[TBL] [Abstract][Full Text] [Related]
5. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
Guarino MP; Carotti S; Sarzano M; Alloni R; Vanni M; Grosso M; Sironi G; Maffettone PL; Cicala M
Neurogastroenterol Motil; 2005 Oct; 17(5):680-6. PubMed ID: 16185306
[TBL] [Abstract][Full Text] [Related]
6. Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.
Mas MR; Comert B; Mas N; Yamanel L; Ozotuk H; Tasci I; Jazrawi RP
World J Gastroenterol; 2007 Aug; 13(32):4336-9. PubMed ID: 17708607
[TBL] [Abstract][Full Text] [Related]
7. Biliary microlithiasis in patients with idiopathic acute pancreatitis and unexplained biliary pain: response to therapy.
Saraswat VA; Sharma BC; Agarwal DK; Kumar R; Negi TS; Tandon RK
J Gastroenterol Hepatol; 2004 Oct; 19(10):1206-11. PubMed ID: 15377301
[TBL] [Abstract][Full Text] [Related]
8. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid.
Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K
Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332
[TBL] [Abstract][Full Text] [Related]
9. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.
van de Heijning BJ; van de Meeberg PC; Portincasa P; Doornewaard H; Hoebers FJ; van Erpecum KJ; Vanberge-Henegouwen GP
Dig Dis Sci; 1999 Jan; 44(1):190-6. PubMed ID: 9952243
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
[TBL] [Abstract][Full Text] [Related]
11. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
[TBL] [Abstract][Full Text] [Related]
12. Effect of gallbladder mucin on the crystallization of cholesterol in bile.
Wilhelmi M; Jüngst C; Mock M; Meyer G; Zündt B; Del Pozo R; Jüngst D
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1301-7. PubMed ID: 15618836
[TBL] [Abstract][Full Text] [Related]
13. Effect of chenodeoxycholate and ursodeoxycholate on nucleation time in human gallbladder bile.
Hirota I; Chijiiwa K; Noshiro H; Nakayama F
Gastroenterology; 1992 May; 102(5):1668-74. PubMed ID: 1568577
[TBL] [Abstract][Full Text] [Related]
14. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
15. Effects of combined treatment with pravastatin and ursodeoxycholic acid on hepatic cholesterol metabolism.
Hillebrant CG; Nyberg B; Gustafsson U; Sahlin S; Björkhem I; Rudling M; Einarsson C
Eur J Clin Invest; 2002 Jul; 32(7):528-34. PubMed ID: 12153554
[TBL] [Abstract][Full Text] [Related]
16. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
Lanzarotto F; Panarotto B; Sorbara R; Panteghini M; Pagani F; Sosta S; Lanzini A
Gut; 1999 Apr; 44(4):552-6. PubMed ID: 10075964
[TBL] [Abstract][Full Text] [Related]
17. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
[TBL] [Abstract][Full Text] [Related]
18. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
19. [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder].
Il'chenko AA; Drozhzhina IuV
Eksp Klin Gastroenterol; 2009; (8):96-101. PubMed ID: 20469685
[TBL] [Abstract][Full Text] [Related]
20. Gallbladder bile composition in patients with Crohn 's disease.
Lapidus A; Akerlund JE; Einarsson C
World J Gastroenterol; 2006 Jan; 12(1):70-4. PubMed ID: 16440420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]